REKA
IL:CO:REKAH
Rekah Pharmaceutical Industries Ltd.
- Stock
Company Information
| msh id | IL:CO:REKAH |
| symbol | REKA |
| name | Rekah Pharmaceutical Industry Ltd. |
| homepage url | https://www.rekah.co.il |
| country | IL |
| sector | Healthcare |
| industry | Drug Manufacturers - Specialty & Generic |
| market | STOCKS |
| employee count | 427 |
| crunchbase url | - |
| linkedin url | - |
| founders | - |
Market Metrics
| market cap | - |
| enterprise value | - |
| stage | - |
| raised capital | - |
| valuation | - |
Web & Growth Metrics
| monthly webtraffic | - |
| monthly webtraffic growth | - |
| growth score 14 | - |
| growth score 28 | - |
| growth score 90 | - |
| growth score 365 | - |
LTM & NTM Metrics
| revenue ltm | - |
| gross profit ltm | - |
| ebitda ltm | - |
| net income ltm | - |
| revenue ntm | - |
| gross profit ntm | - |
| ebitda ntm | - |
| net income ntm | - |
Growth & Performance Metrics
| growth cost and expenses | 0.16 |
| growth cost of revenue | 0.13 |
| growth depreciation and amortization | -0.14 |
| growth ebitda | -0.35 |
| growth ebitda ratio | -0.41 |
| growth eps | - |
| growth eps diluted | - |
| growth general and administrative expenses | 2.59 |
| growth gross profit | 0.02 |
| growth gross profit ratio | -0.07 |
Operating Metrics
| cost and expenses | 86.31M |
| cost of revenue | 86.31M |
| depreciation and amortization | 6.21M |
| ebitda | 6.99M |
| ebitda ratio | 0.08 |
| eps | -0.16 |
| eps diluted | -0.16 |
| operating expenses | 21.41M |
| operating income | 781.04K |
| operating income ratio | 0.01 |
Balance Sheet Metrics
| accounts receivables | 1.83M |
| capital expenditure | -3.09M |
| cash at beginning of period | 5.43M |
| cash at end of period | 5.19M |
| inventory | 25.96M |
| working capital ttm | 96.4M |
Financial Metrics (2022-2026)
| 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|
| Revenue Metrics | |||||
| Revenue | - | - | - | - | - |
| Revenue Growth | - | - | - | - | - |
| Revenue Multiple | - | - | - | - | - |
| Profit Metrics | |||||
| Gross Profit | - | - | - | - | - |
| Gross Profit Growth | - | - | - | - | - |
| Gross Profit Multiple | - | - | - | - | - |
| EBITDA Metrics | |||||
| EBITDA | - | - | - | - | - |
| EBITDA Growth | - | - | - | - | - |
| EBITDA Multiple | - | - | - | - | - |
| Net Income Metrics | |||||
| Net Income | - | - | - | - | - |
| Net Income Growth | - | - | - | - | - |
| Net Income Multiple | - | - | - | - | - |